{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:31:50Z","timestamp":1761823910921,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T00:00:00Z","timestamp":1499212800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s13365-017-0549-5","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T15:35:34Z","timestamp":1499268934000},"page":"763-767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy?"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0148-1075","authenticated-orcid":false,"given":"S.","family":"Mornese Pinna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Scarvaglieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Milia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Imperiale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Ghisetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Audagnotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Prochet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lipani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,5]]},"reference":[{"key":"549_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/514010","volume":"176","author":"HT Agostini","year":"1997","unstructured":"Agostini HT, Ryschkewitsch CF, Mory R, Singer EJ, Stoner GL (1997) JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PML. J Infect Dis 176:1\u20138","journal-title":"J Infect Dis"},{"key":"549_CR2","first-page":"59","volume":"4","author":"J Berger","year":"1998","unstructured":"Berger J, Pall L, Lanska D, Whiteman M (1998) Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neuro-Oncol 4:59\u201368","journal-title":"J Neuro-Oncol"},{"key":"549_CR3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1468-1293.2010.00900.x","volume":"12","author":"E Boffi El Amari","year":"2011","unstructured":"Boffi El Amari E, Combescure C, Yerly S, Calmy A, Kaiser L et al (2011) Clinical relevance of cytomegalovirus viraemia. HIV Med 12:394\u2013402","journal-title":"HIV Med"},{"key":"549_CR4","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/427698","volume":"40","author":"S Bossolasco","year":"2005","unstructured":"Bossolasco S, Calori G, Moretti F, Boschini A, Bertelli D et al (2005) Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 40:738\u2013744","journal-title":"Clin Infect Dis"},{"key":"549_CR5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneurol.2010.164","volume":"6","author":"BJ Brew","year":"2010","unstructured":"Brew BJ, Davies NWS, Cinque P, Clifford DB, Nath A (2010) Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nat Rev Neurol 6:667\u2013669","journal-title":"Nat Rev Neurol"},{"key":"549_CR6","first-page":"88","volume":"22","author":"A Calcagno","year":"2016","unstructured":"Calcagno A, Atzori C, Romito A, Vai D, Audagnotto S et al (2016) Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients. J Neuro-Oncol 22:88\u201392","journal-title":"J Neuro-Oncol"},{"key":"549_CR7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archneurol.2008.557","volume":"66","author":"D Cettomai","year":"2009","unstructured":"Cettomai D, McArthur JC (2009) Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch Neurol 66:255\u2013258","journal-title":"Arch Neurol"},{"key":"549_CR8","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archneurol.2011.103","volume":"68","author":"D Clifford","year":"2011","unstructured":"Clifford D, Ances B, Costello C, Rosen-Schmidt S, Andersson M et al (2011) Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neuro 68:1156\u20131164","journal-title":"Arch Neuro"},{"key":"549_CR9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1128\/JCM.34.5.1343-1346.1996","volume":"34","author":"A Luca De","year":"1996","unstructured":"De Luca A, Cingolani A, Linzalone A, Ammassari A, Murri R et al (1996) Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy. J Clin Microbiol 34:1343\u20131346","journal-title":"J Clin Microbiol"},{"key":"549_CR10","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1086\/315817","volume":"182","author":"A Luca De","year":"2000","unstructured":"De Luca A, Giancola ML, Ammassari A, Grisetti S, Paglia MG et al (2000) The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. J Infect Dis 182:1077\u20131083","journal-title":"J Infect Dis"},{"key":"549_CR11","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","volume":"306","author":"GF Elphick","year":"2004","unstructured":"Elphick GF, Querbes W, Jordan JA et al (2004) Science 306:1380\u20131383","journal-title":"Science"},{"key":"549_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/595299","volume":"199","author":"FN Engsig","year":"2009","unstructured":"Engsig FN, Hansen AB, Omland LH, Kronborg G, Gerstoft J et al (2009) Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis 199:77\u201383","journal-title":"J Infect Dis"},{"key":"549_CR13","doi-asserted-by":"crossref","first-page":"e25571","DOI":"10.1371\/journal.pone.0025571","volume":"6","author":"K Fielding","year":"2011","unstructured":"Fielding K, Koba A, Grant AD, Charalambous S, Day J et al (2011) Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa. PLoS One 6:e25571","journal-title":"PLoS One"},{"key":"549_CR14","first-page":"421","volume":"5","author":"J Gasnault","year":"1999","unstructured":"Gasnault J, Taoufik Y, Goujard C, Kousignian P, Abbed K et al (1999) Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy. J Neuro-Oncol 5:421\u2013429","journal-title":"J Neuro-Oncol"},{"key":"549_CR15","doi-asserted-by":"crossref","first-page":"e20967","DOI":"10.1371\/journal.pone.0020967","volume":"6","author":"J Gasnault","year":"2011","unstructured":"Gasnault J, Costagliola D, Hendel-Chavez H, Dulioust A, Pakianather S et al (2011) Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. PLoS One 6:e20967","journal-title":"PLoS One"},{"key":"549_CR16","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jmv.21618","volume":"81","author":"A Glass","year":"2009","unstructured":"Glass A, Venter M (2009) Improved detection of JC virus in AIDS patients with progressive multifocal leukoencephalopathy by T-antigen specific fluorescence resonance energy transfer hybridization probe real-time PCR: evidence of diverse JC virus genotypes associated with progressive multifocal leukoencephalopathy in Southern Africa. J Med Virol 81:1929\u20131937","journal-title":"J Med Virol"},{"key":"549_CR17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/aje\/kwu098","volume":"180","author":"ER Hammond","year":"2014","unstructured":"Hammond ER, Crum RM, Glenn J et al (2014) The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV. Am J Epidemiol 180:297\u2013307","journal-title":"Am J Epidemiol"},{"key":"549_CR18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.bmt.1705682","volume":"39","author":"RE Kast","year":"2007","unstructured":"Kast RE, Focosi D, Petrini M, AltschulerEL (2007) Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone. Bone Marrow Transplant 39:811\u2013812","journal-title":"Bone Marrow Transplant"},{"key":"549_CR19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-2377-13-200","volume":"13","author":"N Kazuo","year":"2013","unstructured":"Kazuo N, Naoki I, Toshio S, Ichiro K, Chang-Kweng L, Saijo M (2013) Detection of human herpesviruses in the cerebrospinal fluid from patients diagnosed with or suspected of having progressive multifocal leukoencephalopathy. BMC Neurol 13:200","journal-title":"BMC Neurol"},{"key":"549_CR20","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/598335","volume":"48","author":"N Khanna","year":"2009","unstructured":"Khanna N, Elzi L, Mueller NJ, Garzoni C, Cavassini M et al (2009) Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 48:1459\u20131466","journal-title":"Clin Infect Dis"},{"key":"549_CR21","first-page":"35","volume":"17","author":"M Lanzafame","year":"2009","unstructured":"Lanzafame M, Ferrari S, Lattuada E, Corsini F, Deganello R et al (2009) Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy. Infez Med 17:35\u201337","journal-title":"Infez Med"},{"key":"549_CR22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.410370316","volume":"37","author":"D McGuire","year":"1995","unstructured":"McGuire D, Barhite S, Hollander H, Miles M (1995) JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 37:395\u2013399","journal-title":"Ann Neurol"},{"key":"549_CR23","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.24966","volume":"60","author":"E Molloy","year":"2009","unstructured":"Molloy E, Calabrese L (2009) Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 60:3761\u20133765","journal-title":"Arthritis Rheum"},{"key":"549_CR24","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/TP.0b013e31818b62c8","volume":"86","author":"R Neff","year":"2008","unstructured":"Neff R, Hurst F, Falta E, Bohen E, Lentine K et al (2008) Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation 86:1474\u20131478","journal-title":"Transplantation"},{"key":"549_CR25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1086\/597117","volume":"199","author":"CS Tan","year":"2009","unstructured":"Tan CS, Dezube BJ, Bhargava P, Autissier P, W\u00fcthrich C et al (2009) Detection of JC virus DNA and proteins in bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J Infect Dis 199:881\u2013888","journal-title":"J Infect Dis"},{"key":"549_CR26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3851\/IMP3032","volume":"21","author":"A Trentalange","year":"2016","unstructured":"Trentalange A, Calcagno A, Ghisetti V, Atzori C, Busolli P et al (2016) Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis. Antivir Ther 21:633\u2013635","journal-title":"Antivir Ther"},{"key":"549_CR27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1099\/jmm.0.004432-0","volume":"58","author":"Y Wang","year":"2009","unstructured":"Wang Y, Kirby JE, Qian Q (2009) Effective use of JC virus PCR for diagnosis of progressive multifocal leukoencephalopathy. J Med Microbiol 58:253\u2013255","journal-title":"J Med Microbiol"},{"key":"549_CR28","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1128\/JCM.29.10.2130-2138.1991","volume":"29","author":"Y Yogo","year":"1991","unstructured":"Yogo Y, Iidia T, Taguchi F, Kitamura T, Aso Y (1991) Typing of human polyomavirus JC virus on the basis of restriction fragment length polymorphisms. J Clin Microbiol 29:2130\u20132138","journal-title":"J Clin Microbiol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-017-0549-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-017-0549-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-017-0549-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T16:06:53Z","timestamp":1602432413000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-017-0549-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["549"],"URL":"https:\/\/doi.org\/10.1007\/s13365-017-0549-5","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"type":"print","value":"1355-0284"},{"type":"electronic","value":"1538-2443"}],"subject":[],"published":{"date-parts":[[2017,7,5]]}}}